These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 33113251)
1. Interleukin-9-secreting CD4 Gang H; Peng D; Hu Y; Tang S; Li S; Huang Q APMIS; 2021 Feb; 129(2):91-102. PubMed ID: 33113251 [TBL] [Abstract][Full Text] [Related]
2. [The regulatory function of tumor-infiltrating Th9 cells to anti-tumor activity of CD8(+) T cells in patients with gastric cancer]. Sun PS; Gao ZJ; Fan LX; Liu YF; Chen BH; Mu SZ; Yan ZQ Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1186-1193. PubMed ID: 36380667 [No Abstract] [Full Text] [Related]
3. Interleukin-35 Suppresses Interleukin-9-Secreting CD4 Zhang Q; Yang L; Liu S; Zhang M; Jin Z Front Immunol; 2021; 12():645835. PubMed ID: 34177894 [TBL] [Abstract][Full Text] [Related]
4. Th9 cells promote antitumor immunity via IL-9 and IL-21 and demonstrate atypical cytokine expression in breast cancer. You FP; Zhang J; Cui T; Zhu R; Lv CQ; Tang HT; Sun DW Int Immunopharmacol; 2017 Nov; 52():163-167. PubMed ID: 28918288 [TBL] [Abstract][Full Text] [Related]
5. Th9 cells are subjected to PD-1/PD-L1-mediated inhibition and are capable of promoting CD8 T cell expansion through IL-9R in colorectal cancer. Wang C; Lu Y; Chen L; Gao T; Yang Q; Zhu C; Chen Y Int Immunopharmacol; 2020 Jan; 78():106019. PubMed ID: 31776089 [TBL] [Abstract][Full Text] [Related]
6. Circulating Th22 and Th9 levels in patients with acute coronary syndrome. Lin YZ; Wu BW; Lu ZD; Huang Y; Shi Y; Liu H; Liu L; Zeng QT; Wang X; Ji QW Mediators Inflamm; 2013; 2013():635672. PubMed ID: 24453425 [TBL] [Abstract][Full Text] [Related]
7. Characterization of CD4 Zhang X; Gao L; Meng K; Han C; Li Q; Feng Z; Chen L Cell Immunol; 2018 May; 327():62-67. PubMed ID: 29454645 [TBL] [Abstract][Full Text] [Related]
8. CD100 modulates cytotoxicity of CD8 Li Y; Qin L; Bai Q; Zhang J; Chen R; Song K BMC Immunol; 2021 Feb; 22(1):13. PubMed ID: 33593275 [TBL] [Abstract][Full Text] [Related]
9. Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal. Tamang DL; Redelman D; Alves BN; Vollger L; Bethley C; Hudig D Cytokine; 2006 Nov; 36(3-4):148-59. PubMed ID: 17188506 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-7 and interleukin-15 drive CD4+CD28null T lymphocyte expansion and function in patients with acute coronary syndrome. Bullenkamp J; Mengoni V; Kaur S; Chhetri I; Dimou P; Astroulakis ZMJ; Kaski JC; Dumitriu IE Cardiovasc Res; 2021 Jul; 117(8):1935-1948. PubMed ID: 32647892 [TBL] [Abstract][Full Text] [Related]
11. HBV-specific CD4+ cytotoxic T cells in hepatocellular carcinoma are less cytolytic toward tumor cells and suppress CD8+ T cell-mediated antitumor immunity. Meng F; Zhen S; Song B APMIS; 2017 Aug; 125(8):743-751. PubMed ID: 28493520 [TBL] [Abstract][Full Text] [Related]
12. High levels of costimulatory receptors OX40 and 4-1BB characterize CD4+CD28null T cells in patients with acute coronary syndrome. Dumitriu IE; Baruah P; Finlayson CJ; Loftus IM; Antunes RF; Lim P; Bunce N; Kaski JC Circ Res; 2012 Mar; 110(6):857-69. PubMed ID: 22282196 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-35 regulates peripheral T cell activity in patients with Kawasaki disease. Sun M; Xing H Int Immunopharmacol; 2021 Jul; 96():107642. PubMed ID: 33862556 [TBL] [Abstract][Full Text] [Related]
14. Differential development of CD4 and CD8 cytotoxic T cells (CTL) in PBMC across the leprosy spectrum; IL-6 with IFN-gamma or IL-2 generate CTL in multibacillary patients. de la Barrera S; Finiasz DM; Fink S; Valdez R; Bottasso O; Balina LM; Sasiain MC Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):45-55. PubMed ID: 9207753 [TBL] [Abstract][Full Text] [Related]
15. Toll like Receptor 2 engagement on CD4 Karim AF; Reba SM; Li Q; Boom WH; Rojas RE Eur J Immunol; 2017 Sep; 47(9):1513-1524. PubMed ID: 28665005 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection. Raziorrouh B; Ulsenheimer A; Schraut W; Heeg M; Kurktschiev P; Zachoval R; Jung MC; Thimme R; Neumann-Haefelin C; Horster S; Wächtler M; Spannagl M; Haas J; Diepolder HM; Grüner NH Gastroenterology; 2011 Oct; 141(4):1422-31, 1431.e1-6. PubMed ID: 21763239 [TBL] [Abstract][Full Text] [Related]
17. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand. Miura Y; Thoburn CJ; Bright EC; Hess AD Biol Blood Marrow Transplant; 2004 Mar; 10(3):156-70. PubMed ID: 14993881 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-36gamma Mediates the Zhou Y; Chen J; Bai S; Yang F; Yan R; Song Y; Yang B; Li C; Wang J Viral Immunol; 2024; 37(1):24-35. PubMed ID: 38301135 [TBL] [Abstract][Full Text] [Related]
19. [The modulatory activity of T cell immunoglobulin and mucin domain-containing protein 3 on T lymphocytes in patients with chronic heart failure]. Yu HW; Dong YY; Dang YH Zhonghua Yi Xue Za Zhi; 2020 May; 100(17):1315-1319. PubMed ID: 32375439 [No Abstract] [Full Text] [Related]
20. Interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) are necessary in the early stages of induction of CD4 and CD8 cytotoxic T cells by Mycobacterium leprae heat shock protein (hsp) 65 kD. Sasiain MC; de la Barrera S; Fink S; Finiasz M; Alemán M; Fariña MH; Pizzariello G; Valdez R Clin Exp Immunol; 1998 Nov; 114(2):196-203. PubMed ID: 9822276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]